Artiva Biotherapeutics, Inc.
ARTV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $245,580 | $279,379 | $210,999 | $210,999 |
| - Cash | $40,235 | $53,504 | $102,531 | $160,923 |
| + Debt | $14,354 | $16,912 | $19,448 | $1,741 |
| Enterprise Value | $219,699 | $242,787 | $127,916 | $51,817 |
| Revenue | $251 | $33,492 | $4,931 | $2,002 |
| % Growth | -99.3% | 579.2% | 146.3% | – |
| Gross Profit | $251 | $33,492 | $4,931 | $2,002 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$64,851 | -$28,405 | -$58,671 | -$71,577 |
| % Margin | -25,837.1% | -84.8% | -1,189.8% | -3,575.3% |
| Net Income | -$58,493 | -$27,696 | -$58,388 | -$71,825 |
| % Margin | -23,304% | -82.7% | -1,184.1% | -3,587.7% |
| EPS Diluted | -5.2 | -1.19 | -3.32 | -4.08 |
| % Growth | -337% | 64.2% | 18.6% | – |
| Operating Cash Flow | -$55,032 | -$47,430 | -$50,829 | -$15,304 |
| Capital Expenditures | -$642 | -$3,258 | -$6,299 | -$1,724 |
| Free Cash Flow | -$55,674 | -$50,688 | -$57,128 | -$17,028 |